Andrew Luber
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 2
-
- Hepatitis B Virus Studies 5
- Co-authors
- Richard Haubrich (2 shared papers)Courtney V. Fletcher (1 shared paper)Concepta Merry (1 shared paper)David Back (1 shared paper)Giorgio Gatti (1 shared paper)Rodolphe Garaffo (1 shared paper)Richard M. W. Hoetelmans (1 shared paper)Carlo Federico Perno (1 shared paper)
- Journals
- Journal of Hepatology (4 papers)Clinical Infectious Diseases (2 papers)Drugs of today (1 paper)Expert Review of Anti-infective Therapy (1 paper)AIDS (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Andrew Luber
23 papers receiving 398 citations
Peers
Comparison fields: 5 of 73
- Virology 121
- Infectious Diseases 292
- Emergency Medicine 31
- Epidemiology 106
- Hepatology 19
Countries citing papers authored by Andrew Luber
This map shows the geographic impact of Andrew Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Luber more than expected).
Fields of papers citing papers by Andrew Luber
This network shows the impact of papers produced by Andrew Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Luber. The network helps show where Andrew Luber may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Luber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 153 | |
| 2 | 1999 | 86 | |
| 3 | 2000 | 43 | |
| 4 | 2005 | 41 | |
| 5 | 1996 | 23 | |
| 6 | 2007 | 22 | |
| 7 | Use of acid-reducing agents in protease inhibitor-based HAART and the potential for negative treatment outcomes. | 2005 | 10 |
| 8 | K65R-associated virologic failure in HIV-infected patients receiving tenofovir-containing triple nucleoside/nucleotide reverse transcriptase inhibitor regimens. | 2004 | 9 |
| 9 | 2004 | 9 | |
| 10 | 1996 | 5 | |
| 11 | 2024 | 5 | |
| 12 | Prevention of adverse events in hospitalized patients using an antimicrobial review program. | 1999 | 3 |
| 13 | 2022 | 3 | |
| 14 | 2005 | 3 | |
| 15 | 2001 | 3 | |
| 16 | 2012 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2024 | 2 | |
| 20 | CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load. | 2008 | 1 |
About Andrew Luber
Andrew Luber is a scholar working on Infectious Diseases, Epidemiology, Virology, Oncology and Immunology, having authored 23 papers that have together received 430 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers), Hepatitis B Virus Studies (5 papers), Immunotherapy and Immune Responses (3 papers), Optical measurement and interference techniques (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), HIV/AIDS Research and Interventions (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Virology (121 citations), Infectious Diseases (292 citations), Emergency Medicine (31 citations), Epidemiology (106 citations) and Hepatology (19 citations). Andrew Luber has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Richard Haubrich, Courtney V. Fletcher, Concepta Merry, David Back, Giorgio Gatti, Rodolphe Garaffo, Richard M. W. Hoetelmans, Carlo Federico Perno, Michael Kurowski and B. Joseph Guglielmo. Their work appears in journals such as Journal of Hepatology, Clinical Infectious Diseases, Drugs of today, Expert Review of Anti-infective Therapy and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.